3 Things You Should Know About TROP2 as a Therapeutic Target in Triple-Negative Breast Cancer
September 23rd 2025Read an expert-led article on the latest advancements in TROP2-targeted antibody-drug conjugates for treating triple-negative breast cancer and improving patient outcomes.
Improving Leukoplakia Follow-Up: Information Leaflets, Habit Cessation Counseling
Enhancing patient adherence to follow-up care for leukoplakia through habit cessation counseling and patient information leaflets may reduce oral cancer risks.